Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., … Wykoff, C. C. (2025). Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies. Immunotherapy, 17(9), 609–623. https://doi.org/10.1080/1750743X.2025.2449760

Heier, Jeffrey S., Eleonora M. Lad, Frank G. Holz, Philip J. Rosenfeld, Robyn H. Guymer, David Boyer, Federico Grossi, et al. “Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.” Immunotherapy 17, no. 9 (June 2025): 609–23. https://doi.org/10.1080/1750743X.2025.2449760.

Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies. Immunotherapy. 2025 Jun;17(9):609–23.

Heier, Jeffrey S., et al. “Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.” Immunotherapy, vol. 17, no. 9, June 2025, pp. 609–23. Pubmed, doi:10.1080/1750743X.2025.2449760.

Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik J-F, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC. Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies. Immunotherapy. 2025 Jun;17(9):609–623.